Evotec SE

Sector and Industry

Healthcare, Healthcare Services

Performance (1Y)

24.59%

Market Cap

910.14 Mil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-0.58 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
UnitedHealth Group Inc.254.66 Bil.396.73 Bil.24.94
-19.75 %
0.00
-
Thermo Fisher Scientific Inc.185.62 Bil.39.50 Bil.32.67
+1.45 %
0.00
-
Danaher Corp.137.79 Bil.21.78 Bil.45.36
-11.47 %
0.00
-
McKesson Corporation90.13 Bil.348.09 Bil.22.55
+33.83 %
0.00
-
HCA Healthcare Inc.89.28 Bil.67.01 Bil.16.48
+12.93 %
0.00
-
Elevance Health Inc.65.88 Bil.176.51 Bil.13.91
-9.22 %
0.00
-
The Cigna Group61.74 Bil.243.65 Bil.12.41
+66.33 %
0.00
-
Cencora Inc.51.58 Bil.291.15 Bil.39.26
+1.16 %
0.00
-
IDEXX Laboratories Inc.45.92 Bil.3.81 Bil.51.74
+14.41 %
0.00
-
Zoetis Inc.45.52 Bil.8.39 Bil.20.89
+3.10 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE4.968 G0 Units
PRICE DETERMINATION TIME06/03/2026 / 09:55:38 PM
DAILY VOLUME (UNITS)12,044
DAILY HIGH / LOW5.134.968
PREV. DAY'S PRICE5.125 (06/02)
CHANGE DAY BEFORE
-0.16
-3.06 %
52 WEEK HIGH / LOW7.8 (07/30)4.006 (03/13)
More Price Information

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE-0.15-0.41-0.58-1.11-0.47
DIVIDENDS PER SHARE0.000.000.000.000.00
DIVIDEND YIELD IN %--0.00 %0.00 %0.00 %
DIVIDEND GROWTH IN %-----
PRICE - EARNINGS RATIO-----
PRICE - BOOK RATIO--1.191.533.36
PRICE - SALES RATIO--1.231.824.82
PRICE - CASH FLOW RATIO---80.96110.89
Further Key Figures

Master Data

WKN
566480
ISIN
DE0005664809
SYMBOL
EVT
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Evotec
INDEX MEMBERSHIP
TecDAX, SDAX
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Healthcare Services
NUMBER OF SHARES
177.59 Mil.
MARKET CAPITALISATION
910.14 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
2.30 %
-1.44 %
-10.25 %
-7.89 %
-24.59 %
-76.27 %
-85.36 %
-6.31 %
HIGH5.345.605.786.697.8024.4045.626.69
LOW4.824.464.014.014.014.014.014.01
Dividend
per share
Evotec does not deliver dividend information

Company profile

Evotec SE is a life science company, which engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the Shared R&D and Just–Evotec Biologics segments. The Shared R&D segment includes drug discovery and development services and solutions. The Just–Evotec Biologics segment provides services related to designing, discovering, developing, and manufacturing of modern biotherapeutics. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, Charles Weissmann, and Nobel Laureate on December 8, 1993 and is headquartered in Hamburg, Germany.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

(in 8 days)
06/11/26Annual General Meeting
(in 19 days)
06/22/26BIO International Convention
(in 71 days)
08/13/26Q2 2026 Earnings Call
(in 71 days)
08/13/26Q2 2026 Earnings Release
(in 111 days)
09/22/26BioProcess International US East Conference